Advanced Biomed (NASDAQ:ADVB) Stock Price Down 10% – What’s Next?

Advanced Biomed Inc. (NASDAQ:ADVB)’s share price fell 10% on Friday . The stock traded as low as $4.49 and last traded at $4.49. 3,896 shares traded hands during trading, a decline of 90% from the average daily volume of 38,493 shares. The stock had previously closed at $4.99.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Advanced Biomed Trading Down 10.0%

The firm has a market cap of $7.41 million, a PE ratio of 0.93 and a beta of 0.68. The stock’s 50 day simple moving average is $4.83.

Advanced Biomed (NASDAQ:ADVB) last released its earnings results on Friday, May 15th. The company reported ($0.38) EPS for the quarter.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.